Non-Small-Cell Lung Cancers with High and Low Risk of Distant Metastasis Demonstrate Distinct Mutational Landscapes

Background: Preventing metastasis is important for improving the survival rates of patients with non-small-cell lung cancer (NSCLC). Our previous investigation suggested that premalignant epithelial changes in small bronchi distant from the primary tumor serve as predictive markers of NSCLC metastasis. Specifically, isolated basal cell hyperplasia (iBCH) is associated with a high risk of distant metastasis, whereas basal cell hyperplasia combined with squamous metaplasia (BCH + SM) correlates with a low risk of distant metastasis. Methods: This exploratory study included patients enrolled both retrospectively and prospectively. A total of 83 NSCLC patients were stratified into two groups: iBCH (high metastatic risk, n = 59, including 37 metastatic events) and BCH + SM (low metastatic risk, n = 24, including 6 metastatic events). Paired peripheral blood and tumor samples from NSCLC patients with iBCH and BCH + SM were subjected to whole exome sequencing. Bioinformatic analysis included tumor mutation quantification, detection of regions with enriched mutations, mutational signatures profiling, and evaluation of metastasis-free survival and hazard ratio modeling. Results: Patients with iBCH were characterized by a higher prevalence of single nucleotide variants and a lower frequency of frameshift mutations. Single-nucleotide indels (mainly insertions) were more frequent in patients with BCH + SM. Additionally, ID1, ID3, ID11, and ID13 mutational signatures were significantly enriched in patients with BCH + SM. Moreover, the combination of SBS3, SBS4, DBS1, DBS2, DBS6, ID8, and ID23 signatures was linked to distant metastasis in NSCLC patients. Finally, a multivariable logistic regression model for assessing the probability of distant metastasis in NSCLC was developed based on the histological subtype, the bronchial lesion, and mutational signature. Conclusions: NSCLC with high and low risk of distant metastasis defined by bronchial lesions have specific mutational landscapes.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-12
DOI
https://doi.org/10.3390/cancers18223622
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Non-Small-Cell Lung Cancers with High and Low Risk of Distant Metastasis Demonstrate Distinct Mutational Landscapes

Anna Yu. Aksenova, Anna A. Khozyainova, Anastasia A. Schegoleva, D. M. Loos et al.
Cancers
Cancer Genomics and Diagnostics
article

Non-Small-Cell Lung Cancers with High and Low Risk of Distant Metastasis Demonstrate Distinct Mutational Landscapes

Anna Yu. Aksenova, Anna A. Khozyainova, Anastasia A. Schegoleva, D. M. Loos, Olga V. Pankova, Evgeny V. Denisov, E. B. Topolnitskiy, С. В. Миллер, Marina V. Zavyalova, R. S. Vorobev, Н. А. Шефер, Anna S. Zhuk, Е. О. Родионов, Перельмутер Владимир Михайлович, Tatiana S. Gerashchenko, Maria S. Tretyakova, Lilia D. Zhuikova
article en

Abstract

Background: Preventing metastasis is important for improving the survival rates of patients with non-small-cell lung cancer (NSCLC). Our previous investigation suggested that premalignant epithelial changes in small bronchi distant from the primary tumor serve as predictive markers of NSCLC metastasis. Specifically, isolated basal cell hyperplasia (iBCH) is associated with a high risk of distant metastasis, whereas basal cell hyperplasia combined with squamous metaplasia (BCH + SM) correlates with a low risk of distant metastasis. Methods: This exploratory study included patients enrolled both retrospectively and prospectively. A total of 83 NSCLC patients were stratified into two groups: iBCH (high metastatic risk, n = 59, including 37 metastatic events) and BCH + SM (low metastatic risk, n = 24, including 6 metastatic events). Paired peripheral blood and tumor samples from NSCLC patients with iBCH and BCH + SM were subjected to whole exome sequencing. Bioinformatic analysis included tumor mutation quantification, detection of regions with enriched mutations, mutational signatures profiling, and evaluation of metastasis-free survival and hazard ratio modeling. Results: Patients with iBCH were characterized by a higher prevalence of single nucleotide variants and a lower frequency of frameshift mutations. Single-nucleotide indels (mainly insertions) were more frequent in patients with BCH + SM. Additionally, ID1, ID3, ID11, and ID13 mutational signatures were significantly enriched in patients with BCH + SM. Moreover, the combination of SBS3, SBS4, DBS1, DBS2, DBS6, ID8, and ID23 signatures was linked to distant metastasis in NSCLC patients. Finally, a multivariable logistic regression model for assessing the probability of distant metastasis in NSCLC was developed based on the histological subtype, the bronchial lesion, and mutational signature. Conclusions: NSCLC with high and low risk of distant metastasis defined by bronchial lesions have specific mutational landscapes.

CancersVol. 18(22)
Russian Academy of Sciences (RU), St Petersburg University (RU), ITMO University (RU), Siberian State Medical University (RU), Tomsk National Research Medical Center (RU)
Good health and well-being
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon